Keenova Therapeutics plc 10% holder Goldentree Asset Management LP buys $26.4M in MNKTQ shares
An open-market purchase between Nov 5 and Nov 6, reported to the SEC on Nov 9. Information only, not investment advice.
A Form 4 filed on Nov 9 shows Goldentree Asset Management LP, a holder of more than 10% of Keenova Therapeutics plc, buying 295,716 shares worth $26.4 million between Nov 5 and Nov 6, at about $89.25 each.
It is an open-market purchase (transaction code P) of common stock, the kind of trade insiders make with their own money. The filing came 3 days after the trade.
After the trade, the filing lists 8,875,543 shares held.
Details from the SEC filing:
| Company | Keenova Therapeutics plc (MNKTQ) |
|---|---|
| Insider | Goldentree Asset Management LP |
| Role | 10% owner |
| Transaction | Open-market purchase (code P) |
| Shares | 295,716 |
| Average price | $89.25 |
| Value | $26,392,653 |
| Trade dates | Nov 5 to Nov 6, 2026 |
| Filed with the SEC | Nov 9, 2026, 5:30 PM ET |
| Shares held after | 8,875,543 |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
See every transaction in this Keenova Therapeutics plc filing
See all insider activity at Keenova Therapeutics plc · Browse the insider trading newsroom
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
Related Articles
- Insider Trading News
Insider buying and selling on Nov 9: Goldentree Asset Management LP leads with $26.4M
- Insider Trading News
10% owner Saba Capital Management, L.P. buys $103,285 of Gabelli Healthcare & WellnessRx Trust stock
- Insider Trading News
10% owner Venrock Healthcare Capital Partners III, L.P. buys $223,820 of Lycia Therapeutics, Inc. stock
- Insider Trading News
Davita Inc. 10% holder Berkshire Hathaway Inc sells $69M in DVA shares
- Insider Trading News
Basswood Capital Management, L.L.C., a director at Regional Management Corp., sells $1.41M of stock
